Prevalence and predictors of metabolic syndrome among people living with human immunodeficiency virus (PLWHIV)

BACKGROUND: Use of combination antiretroviral therapy (cART) has led to significant reductions in morbidity and mortality. However, there is a growing concern about metabolic syndromes (MS), among patients receiving cART. Despite this fact, there is limited evidence for the prevalence of the MS amon...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosho, Dula Dessalegn, Dube, Lemessa, Mega, Teshale Ayele, Adare, Dawit Abera, Tesfaye, Mikyas Gashaw, Eshetie, Tesfahun Chanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822556/
https://www.ncbi.nlm.nih.gov/pubmed/29483948
http://dx.doi.org/10.1186/s13098-018-0312-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822556/
https://www.ncbi.nlm.nih.gov/pubmed/29483948
http://dx.doi.org/10.1186/s13098-018-0312-y

Ejemplares similares